Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a note issued to investors on Saturday. The firm set a “hold” rating on the stock. Oncternal Therapeutics Price Performance NASDAQ:ONCT opened at $0.53 on Friday. Oncternal Therapeutics has a 12-month low of $0.53 and a 12-month […]
Equities research analysts at StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a note issued to investors on Saturday. The firm set a “hold” rating on the stock. Oncternal Therapeutics Price Performance NASDAQ:ONCT opened at $0.53 on Friday. Oncternal Therapeutics has a 12-month low of $0.53 and a 12-month […]
